- NeuroMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- NeuroMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- NeuroMab™ Anti-Alpha Synuclein BBB Shuttle Antibody,Clone NR1707P (Cat#: NRZP-1022-ZP4050)
- NeuroMab™ Anti-TREM2 BBB Shuttle Antibody, Clone NR19 (Cat#: NRZP-1022-ZP4114)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- NeuroMab™ Anti-GD2 Antibody,Clone NR3007P (Cat#: NRZP-1222-ZP767)
- NeuroMab™ Anti-CD32b Antibody, Clone NR130P (Cat#: NRP-0422-P1803)
- NeuroMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- Tau Monoclonal Antibody (AT120, HT7 and BT2 clone) (Cat#: NK-2106-P008)
- NeuroMab™ Anti-CD20 Antibody,Clone NR3021P (Cat#: NRP-0422-P1230)
- iNeu™ Human Sensory Neurons (Cat#: NCL-2103-P62)
- Mouse Microglia N9 (Cat#: NCL2110P073)
- Human Hippocampal Neuron Cells HPPNCs (Cat#: NCL2110P106)
- Human Dental Pulp Stem Cells (Cat#: NRZP-1122-ZP113)
- Mouse Retinal Ganglion Cell Line RGC-5 (Cat#: NCL2110P154)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- iNeu™ Human Schwann Cell (Cat#: NCL-2103-P63)
- Rat Microglia Cell Line HAPI, Immortalized (Cat#: NCL2110P015)
- Human Blood Brain Barrier Model (Cat#: NCL-2103-P187)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Beta Amyloid (1-40), Aggregation Kit, TTF Assay (Cat#: NRZP-0323-ZP199)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Dextran, NHS Activated, 40 kDa (Cat#: NRZP-0722-ZP124)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- PRV-CAG-EGFP (Cat#: NTA-2011-ZP14)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Dextran-FITC (Cat#: NTA-2011-ZP110)
- pAAV-EF1a-DIO-EGFP-WPRE (Cat#: NTA-2012AD-P285)
- AAV2/9-hEF1a-DIO-mCherry-P2A-TetTox-WPRE-pA (Cat#: NTA-2012-ZP268)
- pAAV-syn-jGCaMP8m-WPRE (Cat#: NTA-2106-P062)
- AAV-mDLX-CRE-tdTomato (Cat#: NRZP-0622-ZP721)
- rAAV-CAG-DIO-G-Flamp1 (Cat#: NRZP-0722-ZP719)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- ABCA1 Antisense Oligonucleotide (AK311445) (Cat#: NV-2106-P27)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein, cTfRMAb-IDUA (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein, cTfRMAb-EPO (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein, cTfRMAb-TNFR (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-ASA BBB Shuttle Protein, HIRMab-ASA (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein, HIRMab-IDUA (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein, HIRMab-NAGLU (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein, HIRMab-SGSH (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein, HIRMab-TNFR (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-EPO BBB Shuttle Protein, HIRMab-EPO (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein, 8D3-IL-1RA (Cat#: NRZP-0423-ZP497)
![](static/images/product/product-icon-neural-antibodies.png)
NeuroMab™ Anti-ApoC3 BBB Shuttle Antibody,Clone NR1738P
- Host Species:
- Human
- Species Reactivity:
- Human; Cynomolgus Monkey
- Applications:
- WB; ELISA; Inhib; In Vitro; In Vivo; Antagonist
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
SPECIFIC INQUIRY
inquiryDescription
Notes: The BBB antibody is made-to order and available in a customized format. Please don't hesitate contact us for more details.
Immunogen
Species Reactivity
Clonality
Host Species
Isotype
Clone Number
Applications
Relevant Diseases
Storage
Research Use Only
Target
Official Name
Full Name
Alternative Names
Figure 1 is a graph showing the interference of ApoC3 antibodies on the binding of ApoC3 to dimyristoylphosphatidylcholine (DMPC).
ELISA microplates were coated with DMPC and incubated with ApoC3 and test anti-ApoC3 antibodies. Measure the amount of ApoC3 still attached to the plate using a biotinylated anti-ApoC3 polyclonal goat antibody following standard procedures for ELISA colorimetric assays.
![](https://img.creative-biolabs.com/neuros/productImages/NRZP-1022-ZP3503-1.png)
Figure 2 shows the binding of ApoC3 to VLDL in the presence of anti-ApoC3 antibody.
![](https://img.creative-biolabs.com/neuros/productImages/NRZP-1022-ZP3503-2.png)
Figure 3 is a graph showing that 14C7 and 13G7 attenuate the ability of ApoC3 to inhibit lipoprotein lipase (LPL) activity. 1
4C7, 13G7, 5E5, or 646 antibodies were incubated with lipid emulsion and purified ApoC3 protein. The production of non-esterified fatty acids (NEFA) was measured and the percentage of NEFA produced compared to that produced by ApoC3 but in the absence of anti-ApoC3 antibody was plotted.
![](https://img.creative-biolabs.com/neuros/productImages/NRZP-1022-ZP3503-3.png)
Figure 4 is a set of graphs showing that certain anti-ApoC3 antibodies attenuate the ability of ApoC3 to inhibit very low density lipoprotein (VLDL) uptake by HepG2 cells.
![](https://img.creative-biolabs.com/neuros/productImages/NRZP-1022-ZP3503-4.png)
Figure 5 shows antibody binding to human ApoC3 (huApoC3) or cvnomolgus monkey ApoC3 (cynoApoC3).
![](https://img.creative-biolabs.com/neuros/productImages/NRZP-1022-ZP3503-5.png)
Figure 6 shows the postprandial triglyceride lowering effect of 5E5.
Mice receiving 3 × 10^11 AAV8-huApoC3 viral particles were administered either vehicle or 5E5 antibody. Oral doses of olive oil were given and triglyceride levels were measured over a period of time.
![](https://img.creative-biolabs.com/neuros/productImages/NRZP-1022-ZP3503-6.png)
Figure 7 shows the postprandial triglyceride lowering effect of 5E5.
The area under curve ("AUC") was reduced by about 25% with 5E5 administration as compared to vehicle control with a p value of 0.030.
![](https://img.creative-biolabs.com/neuros/productImages/NRZP-1022-ZP3503-7.png)
Figure 8 shows the postprandial triglyceride lowering effect of 5E5.
Serum ApoC3 levels were also measured over time.
![](https://img.creative-biolabs.com/neuros/productImages/NRZP-1022-ZP3503-8.png)
Figure 9 shows the postprandial triglyceride lowering effect of 5E5.
5E5 antibody levels were also measured in a time course.
![](https://img.creative-biolabs.com/neuros/productImages/NRZP-1022-ZP3503-9.png)
Figure 10 shows acceleration of ApoC3 and ApoB clearance from blood following subcutaneous injection of 5E5 antibody to mice expressing human ApoC3.
FIG is e graphed as percent difference from negative isotype control
![](https://img.creative-biolabs.com/neuros/productImages/NRZP-1022-ZP3503-10.png)
Publications (0)